Articles tagged "Prophylaxis"

2020 American Transplant Congress
Twice Weekly Valganciclovir for Cytomegalovirus Infection Prophylaxis in Kidney Transplant Recipients with Delayed Graft Function on Hemodialysis
S. A. Mehta¹, A. Katz², R. Dieter², P. Jen², J. Siegfried², J. Papadopoulos², T. Lewis²
¹Infectious Diseases, NYU Langone Health, New York, NY, ²Pharmacy, NYU Langone Health, New York, NY
*Purpose: The incidence of cytomegalovirus (CMV) remains high in the first year following kidney transplantation. Valganciclovir (VGC) is commonly prescribed in the early post-operative period…
2020 American Transplant Congress
Incidence of Oropharyngeal and Esophageal Candidiasis in Adult Kidney Transplant Recipients Receiving Nystatin versus No Prophylaxis
L. Moreno¹, K. Klein¹, C. Long², R. Hall¹, J. Nelson¹
¹Pharmacotherapy and Pharmacy Services, Pharmacotherapy Division, University Health System, The University of Texas Health Science Center at San Antonio, The University of Texas at Austin, College of Pharmacy, San Antonio, TX, ²Pharmacotherapy and Pharmacy Services, Pharmacy Practice, University Health System, University of the Incarnate Word Feik School of Pharmacy, San Antonio, TX
*Purpose: The purpose of this study is to evaluate the need for nystatin prophylaxis for oropharyngeal (OPC) and esophageal Candidiasis (EC) in adult kidney transplant…
2020 American Transplant Congress
Epidemiology of Invasive Fungal Infections in Heart Transplant Recipients
A. Couture-Cossette¹, A. Puing¹, A. Multani², O. Quintero¹, A. K. Subramanian¹, E. Henricksen³, R. Lee¹, Y. Moayedi⁴, K. Khush⁵, J. J. Teuteberg⁵, D. Y. Ho¹
¹Department of Infectious Diseases and Geographic Medicine, Stanford University, Stanford, CA, ²Department of Infectious Diseases, UCLA, Stanford, CA, ³Pharmacy, Stanford Healthtcare, Stanford, CA, ⁴Department of Cardiology, UHN, Toronto, ON, Canada, ⁵Division of Cardiology, Department of Medicine, Stanford University, Stanford, CA
*Purpose: The incidence and epidemiology of invasive fungal infections (IFI) after heart transplantation (HTx) are influenced by changes in environmental exposures, immunosuppression, and prophylaxis practices.…
2020 American Transplant Congress
Does Antibiotic Prophylaxis at Ureteral Stent Removal Reduce Urinary Tract Infections in Kidney Transplant Recipients?
M. Tarokh¹, B. Frainey², M. Fascelli³, D. Goldfarb¹, A. Wee³, M. Eltemamy³
¹Kidney Transplant Surgery, Cleveland Clinic, Cleveland, OH, ²Glickman Urological and Kidney Institute, Urology, Cleveland Clinic, Cleveland, OH, ³Department of Urology, Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, OH
*Purpose: Ureteral stents are commonly placed during kidney transplantation (KT). Urinary tract infections (UTI) are a common risk factor after KT and can have detrimental…
2020 American Transplant Congress
Efficacy and Safety According to Dose of Valganciclovir for Cytomegalovirus Prophylaxis in Transplantation Network Meta Analysis
S. Hwang, W. Park, K. Kim, J. Song, S. Lee
Inha University, Incheon, Korea, Republic of
*Purpose: Valgancivlovir is importantly used to prevent post-transplant CMV infection among kidney transplantation patients. However, the dose of such drug being used still remains controversial…
2020 American Transplant Congress
Efficacy of Single-Strength Trimethoprim-Sulfamethoxazole Thrice Weekly for Pneumocysitis Jirovecii Pneumonia Prophylaxis Post Liver Transplantation
A. Puing, A. Subramanian
Infectious Diseases and Geographic Medicine, Stanford University, Stanford, CA
*Purpose: Current guidelines recommend Pneumocystis jirovecii pneumonia (PJP) prophylaxis for at least 6-12 months after liver transplant (LTx) with preferably Trimethoprim-sulfamethoxazole (TMP-SMX) at a daily…
2020 American Transplant Congress
Once Weekly Fluconazole is Effective for the Prevention of Oral Candidiasis in Kidney Transplant Recipients
J. Lockridge, D. Roberts, K. Spence, M. Stack, S. Rehman, A. Olyaei
OHSU, Portland, OR
*Purpose: Oropharyngeal candidiasis is an infection prevalent in renal transplant recipients, with significant concerns for invasive endoscopic workup and development into invasive fungal infections. While…
2020 American Transplant Congress
Pentamidine Prophylaxis in Transplant Recipients
B. Summers, A. Morrison, N. Sulejmani, R. Kenney
Department of Pharmacy, Henry Ford Hospital, Detroit, MI
*Purpose: Trimethoprim-sulfamethoxazole (TMP-SMX) is preferred therapy for pneumocystis pneumonia (PJP) prophylaxis in solid organ transplant (SOT) recipients, however, use can be limited by allergy and…
2020 American Transplant Congress
Hepatitis B Virus Prophylaxis and Treatment among Hematopoietic Stem Cell Transplant Recipients: Impact on Engraftment and Outcomes
B. Buzo¹, J. Fernandes Ramos², R. Marques Rossetti³, N. Salles⁴, A. Mendrone-Junior⁴, V. Rocha³, A. de Seixas Santos Nastri⁵
¹Division of Infectious Diseases, University of Alberta, Edmonton, AB, Canada, ²Division of Infectious Diseases and Division of Hematology, University of Sao Paulo, Sao Paulo, Brazil, ³Division of Hematology, University of Sao Paulo, Sao Paulo, Brazil, ⁴Fundacao Pro-Sangue, Sao Paulo, Brazil, ⁵Division of Infectious Diseases, University of Sao Paulo, Sao Paulo, Brazil
*Purpose: Hepatitis B virus infection is a worldwide concern with a broad distribution. It can reactivate in immunocompromised populations such as solid organ and hematopoietic…
2020 American Transplant Congress
Incidence of Cytomegalovirus and Role of Reduced Dose Valganciclovir in Kidney Transplant Recipients
A. Szczepanik¹, E. Metzker¹, C. Burrelli¹, K. Chavin²
¹Pharmacy, University Hospitals Cleveland Medical Center, Cleveland, OH, ²Surgery, University Hospitals Cleveland Medical Center, Cleveland, OH
*Purpose: Valganciclovir (VGC) is the optimal agent for preventing cytomegalovirus (CMV) but its use is limited by cost and leukopenia. Reduced dose VGC (rVGC) has…